News

The latest news on HIV prevention, treatment and cure from around the world.
Access to healthcare

Manufacturer’s plans for equitable access to twice-yearly PrEP under fire

Injectable & long-acting PrEP

Once-yearly PrEP moves closer: experimental lenacapavir formulations show promise

PrEP programmes & uptake

Few new HIV cases among Polish PrEP users – most caused by errors with event-based PrEP

Health problems & ageing

CMV antiviral may reduce inflammation and improve immune function in people with HIV

Finance & funding

HIV testing requirements must be simplified for injectable PrEP to have a future

 

News and research from CROI 2025.

PrEP policies & guidelines

Simpler PrEP services – fewer check-ups, online care – work as well as the standard approach

 

Broadcasts and digital media with information, news and discussion about HIV.

Cardiovascular disease

Beyond cholesterol: statins may protect heart health in people with HIV through multiple mechanisms

Cardiovascular disease

Coronary artery disease uncommon in people with HIV in Uganda

Sexually transmitted infections prevention

Why aren’t more people with HIV accessing doxyPEP?

PrEP science

HIV acquisition in women with good adherence to TAF/FTC PrEP is rare

Injectable & long-acting HIV treatment

New long-acting HIV drugs show promising early results

Antibody-based treatment

Broadly neutralising antibody N6LS could be part of long-acting HIV treatment

Injectable & long-acting PrEP

Injectable PrEP use leads to zero new HIV infections among gay, trans and non-binary Brazilians

Retention & linkage to care

Positive interactions with healthcare workers improve HIV care retention in Malawi and Zambia

New & experimental HIV treatments

Studies confirm non-inferiority of doravirine / islatravir to standard HIV treatment

Health problems & ageing

Large fall in severe illnesses over two decades in Spain, while co-morbidities stay stable

PrEP science

Event-driven PrEP for women may work, modelling study predicts

Retention & linkage to care

PEPFAR study shows the deadly impact of stopping children’s HIV treatment

Injectable & long-acting HIV treatment

Lenacapavir plus broadly neutralising antibodies could be twice-yearly HIV treatment

Antibody-based treatment

Half the men in an HIV cure study stayed off treatment for nearly a year after a two-antibody shot

Global health initiatives

Radical changes in US policy threaten two decades’ progress in HIV

The search for a cure

Two more people with HIV may be cured after stem cell transplants

NAM news & opinion

aidsmap returns with reporting from the Conference on Retroviruses and Opportunistic Infections (CROI)

NAM news & opinion

Accessible HIV science is vital in an age of disinformation

NAM news & opinion

Public Statement: Transition of Aidsmap and NAM Publications' Assets to Terrence Higgins Trust and National AIDS Trust

Epidemiology

Much lower HIV knowledge and access to testing for people with disabilities globally

Cancer

Uganda achieves rapid scale-up of cervical screening for women living with HIV

Changing treatment

Dolutegravir resistance very rare after a switch - even with detectable HIV

close